Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.

Saxena D, Spino M, Tricta F, Connelly J, Cracchiolo BM, Hanauske AR, D'Alliessi Gandolfi D, Mathews MB, Karn J, Holland B, Park MH, Pe'ery T, Palumbo PE, Hanauske-Abel HM.

PLoS One. 2016 May 18;11(5):e0154842. doi: 10.1371/journal.pone.0154842. eCollection 2016.

2.

Depressive symptoms in neurodegenerative diseases.

Baquero M, Martín N.

World J Clin Cases. 2015 Aug 16;3(8):682-93. doi: 10.12998/wjcc.v3.i8.682. Review.

4.

Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Hsiao JJ, Teng E.

Neurodegener Dis Manag. 2013;3(2):147-155.

5.
6.

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders.

Lai CK.

Clin Interv Aging. 2014 Jul 8;9:1051-61. doi: 10.2147/CIA.S63504. eCollection 2014. Review.

7.

The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis.

Killin LO, Russ TC, Starr JM, Abrahams S, Della Sala S.

BMJ Open. 2014 Apr 7;4(4):e004083. doi: 10.1136/bmjopen-2013-004083.

8.

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Herrmann N, Lanctôt KL, Hogan DB.

Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S5. doi: 10.1186/alzrt201. Epub 2013 Jul 8.

9.

The threat of behavioral changes in dementia.

Burke AD, Yaari R, Tariot PN, Hall GR, Dougherty J, Brand H, Fleisher AS.

Prim Care Companion CNS Disord. 2013;15(1). pii: PCC.13alz01507. doi: 10.4088/PCC.13alz01507. Epub 2013 Feb 28. No abstract available.

10.

Conformational analysis and parallel QM/MM X-ray refinement of protein bound anti-Alzheimer drug donepezil.

Fu Z, Li X, Miao Y, Merz KM Jr.

J Chem Theory Comput. 2013 Dec 3;9(3):1686-1693. Epub 2013 Feb 18.

11.

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.

Huang YJ, Lin CH, Lane HY, Tsai GE.

Curr Neuropharmacol. 2012 Sep;10(3):272-85. doi: 10.2174/157015912803217288.

13.

Behavioral and psychological symptoms of dementia.

Cerejeira J, Lagarto L, Mukaetova-Ladinska EB.

Front Neurol. 2012 May 7;3:73. doi: 10.3389/fneur.2012.00073. eCollection 2012.

14.
15.

Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.

Aisen PS, Cummings J, Schneider LS.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006395. doi: 10.1101/cshperspect.a006395. Review.

17.

Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.

Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST.

Arch Gen Psychiatry. 2011 Jan;68(1):51-60. doi: 10.1001/archgenpsychiatry.2010.184.

18.

Ethical issues in diagnosing and treating Alzheimer disease.

Howe EG.

Psychiatry (Edgmont). 2006 May;3(5):43-53.

19.

Managing medications in clinically complex elders: "There's got to be a happy medium".

Steinman MA, Hanlon JT.

JAMA. 2010 Oct 13;304(14):1592-601. doi: 10.1001/jama.2010.1482. Review.

20.

Supplemental Content

Support Center